Neosoma Incorporates Wholly-Owned Swiss Subsidiary
Neosoma, Inc., developer of a software medical device platform to help advance brain cancer care and clinical trials, announced the
Neosoma, Inc., developer of a software medical device platform to help advance brain cancer care and clinical trials, announced the
Neosoma, Inc., developer of a software medical device platform to help advance brain cancer care and clinical trials, announced the incorporation of a wholly-owned subsidiary
Artificial intelligence does not change anything about the fundamental nature of sustained competitive advantage when its use is pervasive. Once #AI’s use is ubiquitous, it will transform economies and lift markets as a whole, but it will not uniquely benefit any single company.